All In MedTech

Device Trial Radar · NCT04655989

A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System

A Prospective, Multi-Center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System in Adult Patients With Chronic Renal Failure

Last checked: Nov 20, 2026Latest source record: Oct 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Nov 30, 2020

Primary completion

Feb 24, 2021

Study completion May 1, 2021

Sponsor

Lead sponsor
Nikkiso America, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
NAMSA
First posted
Dec 7, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study objective is to verify the safety and effectiveness of the DBB-EXA ES Hemodialysis Delivery System to consistently deliver dialysate of the appropriate quality for infusion.

Conditions

  • Dialysis
  • Chronic Renal Failure

Interventions

  • DBB-EXA ES Hemodialysis SystemDevice

    The DBB-EXA ES Hemodialysis Delivery System is intended to support an optional online priming, rinseback and emergency bolus features. The appropriate priming of the hollow fiber dialyzer and blood tubing lines removes debris and air prior to device use, as well as ensuring proper rinseback.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Event RateTime frame: 8 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Great Lakes Dialysis

    Detroit, Michigan

  • Great Lakes Dialysis - West

    Southfield, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.